Target intelligence / Profile preview

Nonelective trace element supplementation (null)

Target
null
01

Overview

Nonelective trace element supplementation refers to the routine addition of essential micronutrients—such as zinc, copper, manganese, selenium (and sometimes chromium and others)—to parenteral nutrition regimens for patients unable to receive adequate nutrition enterally. This practice is critical in preventing deficiencies that can lead to impaired immune function, delayed wound healing, metabolic disturbances and other complications. The term "nonelective" indicates that these supplements are considered mandatory for long-term parenteral nutrition rather than optional additions. However, this is not a single molecule or receptor but rather a clinical strategy involving several distinct inorganic nutrients with diverse physiological roles as enzyme cofactors and structural components. Dosing must be individualized based on patient needs and monitored closely due to the narrow margin between deficiency and toxicity for some elements. Note: "Nonelective trace element supplementation" is not itself a molecular target such as an enzyme or receptor—it describes a therapeutic approach using multiple compounds.

Other names
Trace element supplementationParenteral trace element supplementationTPN trace elementsMulti-trace element injection
02

Mechanism of action

Not applicable; this is not a molecular target but a clinical intervention involving multiple essential micronutrients

03

Safety considerations

Risk of deficiency if omitted or underdosed (impaired immunity, poor wound healing, metabolic dysfunction)Risk of toxicity if overdosed (neurological damage from manganese/copper accumulation; liver dysfunction; selenium toxicity)Monitoring challenges due to complex interactions and contamination risks
04

Interacting drugs

Tralement

2 more in the full profile.

05

Biomarkers

Serum/plasma/tissue levels of individual trace elements (e.g., zinc, copper, selenium)Clinical symptoms of deficiency or toxicity

Beyond the preview

Go deeper on Nonelective trace element supplementation (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nonelective trace element supplementation (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call